Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/03/22 07:00:00 on US and Canada Markets.
– Record Second Quarter Revenue up 10.3% to $180.3 Million; up 13.7% on a Constant Currency Basis – – Net Income attributable to Controlling Interest of $11.1 Million, or $0.32 Per Share – – Adjusted EPS of $0.20 – ...
Ceragon Confirms Receipt of Revised Non-binding Indication of Interest from Aviat Networks PR Newswire Shareholders are Not Required to Take any Action at this Time ROSH HA 'AIN, Israel , Aug. 3, 2022 /PRNewswire/ -- Ceragon Networks Ltd...
Investment Management continues to scale, further increasing recurring earnings Second quarter operating highlights: TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (NASDAQ and TSX: CIGI) (“Colliers” or the “Company”) ...
CECO ENVIRONMENTAL TO PRESENT AT THE UPCOMING JEFFERIES INDUSTRIALS CONFERENCE AND MIDWEST IDEAS CONFERENCE PR Newswire DALLAS , Aug. 3, 2022 /PRNewswire/ -- CEC O Environmental Corp. (Nasdaq: CECE), a leading environmentally focused, di...
Reinforces Power of Business Model and Strategy CDW Corporation (Nasdaq: CDW): CDW Corporation (Nasdaq: CDW), a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in the United States, the United K...
Harley-Davidson Appoints Rafeh Masood to Board of Directors PR Newswire MILWAUKEE , Aug. 3, 2022 /PRNewswire/ -- Harley-Davidson, Inc. ("Harley-Davidson") (NYSE:HOG) announced today that its board of directors has appointed Rafeh Masood as a member of...
Company Received Final Positive Reimbursement Decision for VAZKEPA ® by UK’s NICE in England & Wales Market Access Negotiations and Launch Preparations for VAZKEPA Underway Across Multiple European Markets Initiated Comprehensive Cost Reduction Plan i...
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived bi...
WAYNE, Pa., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the second quarter of 2022 and provided...
BROOKFIELD, News, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the second quarter ended June 30, 2022. “We generated record financial resul...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.62%Change Percent:
Biodexa Pharmaceuticals PLC-ADR Company Name:
BDRX Stock Symbol:
NASDAQ Market:
midatechpharma.com Website: